Clinical trial Recruiting at 1 site Interventional

Linking dementia caregivers to assistance and resources (DECLARE)

Official title: Dementia Caregivers' Link to Assistance and Resources: Supporting Caregivers of Home Health Patients With Dementia

Run by Visiting Nurse Service of New York · NCT06860035 · Data updated 2026-11-12

This program tests whether a short caregiver self-assessment plus easier access to social work helps family caregivers of home health patients with dementia feel more supported and confident in their caregiving role.

Quick facts

Study typeInterventional
SexAll
Enrollment200 (estimated)
SponsorVisiting Nurse Service of New York
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMay 5, 2025
Main results expectedApril 30, 2026
Study endsJune 30, 2026
Registry record updatedMarch 13, 2026
Trial IDNCT06860035 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are English-speaking family caregivers listed in the record for home health patients aged 65+ with a documented dementia diagnosis who receive care from participating VNS Health branches and have a phone number on file.

Probably not a fit

Caregivers who are not listed in the patient record, cannot communicate in English, lack a phone number, or are caring for patients without a documented dementia diagnosis or not served by VNS Health are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

DECLARE is a pragmatic, cluster-randomized program embedded within VNS Health home health operations that integrates a caregiver self-assessment into the patient record and facilitates increased social work involvement for cases with dementia caregivers. Four treatment branches (8 clinical teams) will implement the intervention and six control branches (12 clinical teams) will provide usual care. Caregivers will be contacted by phone for baseline and follow-up surveys while clinicians will have access to assessment responses in the electronic record to guide referrals to social work. The pilot will run about 12 months with periodic analytic checks to monitor uptake, usefulness to clinicians, and changes in caregiver outcomes.

Why it matters

Potential benefit: If successful, the program could increase caregiver confidence and connect more families to social work and community resources when dementia care needs are high.

How similar studies have gone: Previous caregiver-support and social work linkage programs have shown benefits for caregiver strain and confidence, but this specific checklist-based intervention in the home health setting is novel and being piloted.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individual must be listed as the caregiver of record for a patient receiving home health care from the partner home health agency and have a phone number on file; the patient must meet the inclusion criteria listed below.
* Home health patient (care recipient) must have a documented dementia diagnosis on the home health assessment, be 65 years or older, and have Traditional Medicare or Medicare Advantage as their primary payer for the home health episode.

Exclusion Criteria:

* Caregivers are excluded if they are unable to communicate in English.

Where it's running

  • VNS Health Home Care
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.